Inhibitors & Compound Libraries

Name	Typ	Specific against	Appl.	ArtNr.	Menge	Preis
Emraclidine	Inhibitors	Other		DCC-DC46844-1g DCChemicals	1 g	Anmelden Vergleichen	Emraclidine
Cyclizine	Inhibitors	Other		DCC-DC47622-100mg DCChemicals	100 mg	Anmelden Vergleichen	Cyclizine
Cyclizine	Inhibitors	Other		DCC-DC47622-250mg DCChemicals	250 mg	Anmelden Vergleichen	Cyclizine
Cyclizine	Inhibitors	Other		DCC-DC47622-1g DCChemicals	1 g	Anmelden Vergleichen	Cyclizine
CVN03650(IL-17 modulator 4)	Inhibitors	Other		DCC-DC46954-10mg DCChemicals	10 mg	Anmelden Vergleichen	CVN03650(IL-17 modulator 4)
Iclepertin	Inhibitors	Other		DCC-DC46952-250mg DCChemicals	250 mg	Anmelden Vergleichen	Iclepertin
Iclepertin	Inhibitors	Other		DCC-DC46952-1g DCChemicals	1 g	Anmelden Vergleichen	Iclepertin
Thalidomide-5,6-F	Inhibitors	Other		DCC-DC47216-250mg DCChemicals	250 mg	Anmelden Vergleichen	Thalidomide-5,6-F
Thalidomide-5,6-F	Inhibitors	Other		DCC-DC47216-1g DCChemicals	1 g	Anmelden Vergleichen	Thalidomide-5,6-F
PROTAC SHP2 degrader-1	Inhibitors	Other		DCC-DC47388-100mg DCChemicals	100 mg	Anmelden Vergleichen	PROTAC SHP2 degrader-1
PROTAC SHP2 degrader-1	Inhibitors	Other		DCC-DC47388-250mg DCChemicals	250 mg	Anmelden Vergleichen	PROTAC SHP2 degrader-1
PROTAC SHP2 degrader-1	Inhibitors	Other		DCC-DC47388-1g DCChemicals	1 g	Anmelden Vergleichen	PROTAC SHP2 degrader-1
Ziftomenib	Inhibitors	Other		DCC-DC46835-5mg DCChemicals	5 mg	Anmelden Vergleichen	Ziftomenib
Etavopivat	Inhibitors	Other		DCC-DC47090-5mg DCChemicals	5 mg	Anmelden Vergleichen	Etavopivat
SSAA09E2	Inhibitors	Other	ELISA, Blocking	DCC-DC42577-100mg DCChemicals	100 mg	Anmelden Vergleichen	SSAA09E2
SSAA09E2	Inhibitors	Other	ELISA, Blocking	DCC-DC42577-250mg DCChemicals	250 mg	Anmelden Vergleichen	SSAA09E2
CHR-6494 TFA salt	Inhibitors	Other	First-in-class Haspin inhibitor with a wide spectrum of anticancer effects	DCC-DC43041-250mg DCChemicals	250 mg	Anmelden Vergleichen	CHR-6494 TFA salt
CHR-6494 TFA salt	Inhibitors	Other	First-in-class Haspin inhibitor with a wide spectrum of anticancer effects	DCC-DC43041-1g DCChemicals	1 g	Anmelden Vergleichen	CHR-6494 TFA salt
ARD-2128	Inhibitors	Other	ARD2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has the potential for the research of the prostate cancer.	DCC-DC46405-100mg DCChemicals	100 mg	Anmelden Vergleichen	ARD-2128
CCF0058981	Inhibitors	Other	IC	DCC-DC46358-100mg DCChemicals	100 mg	Anmelden Vergleichen	CCF0058981
CCF0058981	Inhibitors	Other	IC	DCC-DC46358-250mg DCChemicals	250 mg	Anmelden Vergleichen	CCF0058981
CCF0058981	Inhibitors	Other	IC	DCC-DC46358-1g DCChemicals	1 g	Anmelden Vergleichen	CCF0058981
Rimtuzalcap	Inhibitors	Other	Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and	DCC-DC47376-100mg DCChemicals	100 mg	Anmelden Vergleichen	Rimtuzalcap
Rimtuzalcap	Inhibitors	Other	Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and	DCC-DC47376-250mg DCChemicals	250 mg	Anmelden Vergleichen	Rimtuzalcap
Rimtuzalcap	Inhibitors	Other	Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and	DCC-DC47376-1g DCChemicals	1 g	Anmelden Vergleichen	Rimtuzalcap

Name Preis

Emraclidine

Anmelden

Emraclidine

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC46844-1g
Menge	1 g
Lieferbar

Cyclizine

Anmelden

Cyclizine

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47622-100mg
Menge	100 mg
Lieferbar

Cyclizine

Anmelden

Cyclizine

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47622-250mg
Menge	250 mg
Lieferbar

Cyclizine

Anmelden

Cyclizine

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47622-1g
Menge	1 g
Lieferbar

CVN03650(IL-17 modulator 4)

Anmelden

CVN03650(IL-17 modulator 4)

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC46954-10mg
Menge	10 mg
Lieferbar

Iclepertin

Anmelden

Iclepertin

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC46952-250mg
Menge	250 mg
Lieferbar

Iclepertin

Anmelden

Iclepertin

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC46952-1g
Menge	1 g
Lieferbar

Thalidomide-5,6-F

Anmelden

Thalidomide-5,6-F

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47216-250mg
Menge	250 mg
Lieferbar

Thalidomide-5,6-F

Anmelden

Thalidomide-5,6-F

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47216-1g
Menge	1 g
Lieferbar

PROTAC SHP2 degrader-1

Anmelden

PROTAC SHP2 degrader-1

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47388-100mg
Menge	100 mg
Lieferbar

PROTAC SHP2 degrader-1

Anmelden

PROTAC SHP2 degrader-1

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47388-250mg
Menge	250 mg
Lieferbar

PROTAC SHP2 degrader-1

Anmelden

PROTAC SHP2 degrader-1

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47388-1g
Menge	1 g
Lieferbar

Ziftomenib

Anmelden

Ziftomenib

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC46835-5mg
Menge	5 mg
Lieferbar

Etavopivat

Anmelden

Etavopivat

Typ	Inhibitors
Clone
Specific against	Other
Appl.
Host
ArtNr.	DCC-DC47090-5mg
Menge	5 mg
Lieferbar

SSAA09E2

Anmelden

SSAA09E2

Typ	Inhibitors
Clone
Specific against	Other
Appl.	ELISA, Blocking
Host
ArtNr.	DCC-DC42577-100mg
Menge	100 mg
Lieferbar

SSAA09E2

Anmelden

SSAA09E2

Typ	Inhibitors
Clone
Specific against	Other
Appl.	ELISA, Blocking
Host
ArtNr.	DCC-DC42577-250mg
Menge	250 mg
Lieferbar

CHR-6494 TFA salt

Anmelden

CHR-6494 TFA salt

Typ	Inhibitors
Clone
Specific against	Other
Appl.	First-in-class Haspin inhibitor with a wide spectrum of anticancer effects
Host
ArtNr.	DCC-DC43041-250mg
Menge	250 mg
Lieferbar

CHR-6494 TFA salt

Anmelden

CHR-6494 TFA salt

Typ	Inhibitors
Clone
Specific against	Other
Appl.	First-in-class Haspin inhibitor with a wide spectrum of anticancer effects
Host
ArtNr.	DCC-DC43041-1g
Menge	1 g
Lieferbar

ARD-2128

Anmelden

ARD-2128

Typ	Inhibitors
Clone
Specific against	Other
Appl.	ARD2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has the potential for the research of the prostate cancer.
Host
ArtNr.	DCC-DC46405-100mg
Menge	100 mg
Lieferbar

CCF0058981

Anmelden

CCF0058981

Typ	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
ArtNr.	DCC-DC46358-100mg
Menge	100 mg
Lieferbar

CCF0058981

Anmelden

CCF0058981

Typ	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
ArtNr.	DCC-DC46358-250mg
Menge	250 mg
Lieferbar

CCF0058981

Anmelden

CCF0058981

Typ	Inhibitors
Clone
Specific against	Other
Appl.	IC
Host
ArtNr.	DCC-DC46358-1g
Menge	1 g
Lieferbar

Rimtuzalcap

Anmelden

Rimtuzalcap

Typ	Inhibitors
Clone
Specific against	Other
Appl.	Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and
Host
ArtNr.	DCC-DC47376-100mg
Menge	100 mg
Lieferbar

Rimtuzalcap

Anmelden

Rimtuzalcap

Typ	Inhibitors
Clone
Specific against	Other
Appl.	Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and
Host
ArtNr.	DCC-DC47376-250mg
Menge	250 mg
Lieferbar

Rimtuzalcap

Anmelden

Rimtuzalcap

Typ	Inhibitors
Clone
Specific against	Other
Appl.	Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and
Host
ArtNr.	DCC-DC47376-1g
Menge	1 g
Lieferbar

Inhibitors & Compound Libraries

Kontakt

Über Hölzel

Service

Infothek

ANMELDEN & VORTEILE SICHERN

Ergebnisse filtern

Inhibitors & Compound Libraries

Kontakt

Über Hölzel

Service

Infothek